Search | IOVS | ARVO Journals

Showing 1 – 19 of 19

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina March 2019

Reduced Vessel Density of the Choriocapillaris during Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration

PDF

Taiichi Hikichi; Mitsuko Agarie
TAGS: anti-vascular endothelial growth factor therapy, chief complaint, exudative age-related macular degeneration, eye, atrophy, follow-up, injections
Invest. Ophthalmol. Vis. Sci.. 2019; 60(4):1088-1095. doi: https://doi.org/10.1167/iovs.18-24522

ARVO Annual Meeting Abstract July 2018

Macular capillary plexuses during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration

Taiichi Hikichi; Mitsuko Agarie

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1444. doi:

ARVO Annual Meeting Abstract June 2017

OVOL2 maintains a transcriptional program in human corneal epithelial cells

Koji Kitazawa; Takafusa Hikichi; Takahiro Nakamura; Chie Sotozono; Shigeru Kinoshita; Shinji Masui

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2624. doi:

ARVO Annual Meeting Abstract June 2017

PAX6, OVOL2, KLF4 coordinately contribute the reprogramming of the corneal epithelial cellsTranscription factors PAX6, OVOL2, and KLF4 coordinately contribute to the reprogramming of corneal epithelial cells

Rei Murakami; Koji Kitazawa; Takafusa Hikichi; Takahiro Nakamura; Chie Sotozono; Shigeru Kinoshita; Shinji Masui

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4244. doi:

ARVO Annual Meeting Abstract September 2016

Loss of human corneal epithelial cell identity exhibited by deletion of PAX6 using the CRISPR/Cas9 system

Koji Kitazawa; Takafusa Hikichi; Takahiro Nakamura; Chie Sotozono; Shigeru Kinoshita; Shinji Masui

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract June 2015

Risk characteristics of progressing retinal pigment epithelial atrophy during ranibizumab therapy for polypoidal choroidal vasculopathy

Taiichi Hikichi; Hirokuni Kitamei; Shoko Shioya

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2842. doi:

ARVO Annual Meeting Abstract April 2014

INDIVIDUALIZED RANIBIZUMAB MONOTHERAPY STRATEGIES DURING 3 AFTER AS-NEEDED TREATMENT BASED ON MONTHLY EXAMINATIONS FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

Taiichi Hikichi; Hirokuni Kitamei; Shoko Shioya

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3884. doi:

ARVO Annual Meeting Abstract June 2013

CORRELATION BETWEEN CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AND 1-YEAR OUTCOMES OF RANIBIZUMAB THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

Taiichi Hikichi; Hirokuni Kitamei; Shoko Shioya; Makoto Higuchi; Takuro Matsushita; Shoko Kosaka; Reiko Matsushita; Kimitaka Takami; Hideo Ohtsuka

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4099. doi:

ARVO Annual Meeting Abstract March 2012

Factors Predictive Of Outcomes 1 Year After Ranibizumab Therapy In Japanese Patients With Polypoidal Choroidal Vasculopathy

Taiichi Hikichi; Makoto Higuchi; Takuro Matsushita; Shoko Kosaka; Reiko Matsushita; Kimitaka Takami; Hideo Ohtsuka; Hiroko Ariga

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2058. doi:

ARVO Annual Meeting Abstract April 2011

Vascular Changes Of Polypoidal Choroidal Vasculopathy 1 Year After Ranibizumab Therapy

Taiichi Hikichi; Makoto Higuchi; Takuro Matsushita; Hiroko Ariga; Shoko Kosaka; Reiko Matsushita; Kimitaka Takami; Hideo Ohtsuka

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):128. doi:

ARVO Annual Meeting Abstract April 2010

Improvement of Angiographic Findings of Polypoidal Choroidal Vasculopathy After Induction Phase of Ranibizumab Therapy

T. Hikichi; H. Ohtsuka; M. Higuchi; T. Matsushita; H. Ariga; S. Kosaka; R. Matsushita; K. Takami

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):516. doi:

ARVO Annual Meeting Abstract April 2009

Serum Concentration of Triamcinolone Acetonide Used for Visualization During Vitrectomy

T. Hikichi; S. Kosaka; K. Takami; H. Ohtsuka; M. Higuchi; T. Matsushita; H. Ariga; R. Matsushita

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):4441. doi:

ARVO Annual Meeting Abstract May 2007

Recurrence of Polypoidal Lesions at the Terminus of Residual Abnormal Choroidal Vessels After Photodynamic Therapy in Eyes With Polypoidal Choroidal Vasculopathy

T. Hikichi; H. Ohtsuka; M. Higuchi; T. Matsushita; H. Ariga; S. Kosaka; R. Matsushita

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1798. doi:

ARVO Annual Meeting Abstract May 2006

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia in Japanese Patients

T. Hikichi; H. Ohtsuka; M. Higuchi; T. Matsushita; H. Ariga; R. Matsushita; S. Kosaka

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):350. doi:

ARVO Annual Meeting Abstract May 2005

A Peptide Corresponding to Handle Region for Nonproteolytic Activation of Prorenin Inhibits Retinal Neovascularization in a Retinopathy of Prematurity Model

H. Yokota; A. Takamiya; T. Nagaoka; N. Kitaya; F. Mori; T. Hikichi; A. Yoshida; Y. Ishida; F. Suzuki

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):4108. doi:

ARVO Annual Meeting Abstract May 2003

Nitric Oxide Mediates Glucose-Induced Apoptosis in Long-Term Cultured Retinal Pericytes

T. Hikichi; M. Sasaki; A. Yoshida; N. Shishido; M. Nakamura; K. Ishikawa; J. Iwamoto; Y. Hayashi

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3885. doi:

ARVO Annual Meeting Abstract May 2003

Poly (ADP-Ribose) Polymerase Inhibitor (PJ34) Inhibits Leukocyte Entrapment in the Retinal Microcirculation of Diabetic Rats

R. Sugawara; T. Hikichi; N. Kitaya; F. Mori; T. Nagaoka; A. Yoshida; C. Szabo

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3898. doi:

ARVO Annual Meeting Abstract May 2003

Effect of Adenosine on Outward Active Transport of Fluorescein across Rabbit Blood Retinal Barrier

A. Kawahara; T. Hikichi; J. Takahashi; N. Kitaya; F. Mori; A. Yoshida

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):401. doi:

ARVO Annual Meeting Abstract December 2002

Effect of P2Y2 Receptor Agonist (INS542) on the Outward Permeability of the Retinal Pigment Epithelium

J Takahashi; T Hikichi; F Mori; A Yoshida

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):3265. doi:

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Reduced Vessel Density of the Choriocapillaris during Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration

Macular capillary plexuses during anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration

OVOL2 maintains a transcriptional program in human corneal epithelial cells

PAX6, OVOL2, KLF4 coordinately contribute the reprogramming of the corneal epithelial cellsTranscription factors PAX6, OVOL2, and KLF4 coordinately contribute to the reprogramming of corneal epithelial cells

Loss of human corneal epithelial cell identity exhibited by deletion of PAX6 using the CRISPR/Cas9 system

Risk characteristics of progressing retinal pigment epithelial atrophy during ranibizumab therapy for polypoidal choroidal vasculopathy

INDIVIDUALIZED RANIBIZUMAB MONOTHERAPY STRATEGIES DURING 3 AFTER AS-NEEDED TREATMENT BASED ON MONTHLY EXAMINATIONS FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

CORRELATION BETWEEN CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AND 1-YEAR OUTCOMES OF RANIBIZUMAB THERAPY FOR POLYPOIDAL CHOROIDAL VASCULOPATHY

Factors Predictive Of Outcomes 1 Year After Ranibizumab Therapy In Japanese Patients With Polypoidal Choroidal Vasculopathy

Vascular Changes Of Polypoidal Choroidal Vasculopathy 1 Year After Ranibizumab Therapy

Improvement of Angiographic Findings of Polypoidal Choroidal Vasculopathy After Induction Phase of Ranibizumab Therapy

Serum Concentration of Triamcinolone Acetonide Used for Visualization During Vitrectomy

Recurrence of Polypoidal Lesions at the Terminus of Residual Abnormal Choroidal Vessels After Photodynamic Therapy in Eyes With Polypoidal Choroidal Vasculopathy

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia in Japanese Patients

A Peptide Corresponding to Handle Region for Nonproteolytic Activation of Prorenin Inhibits Retinal Neovascularization in a Retinopathy of Prematurity Model

Nitric Oxide Mediates Glucose-Induced Apoptosis in Long-Term Cultured Retinal Pericytes

Poly (ADP-Ribose) Polymerase Inhibitor (PJ34) Inhibits Leukocyte Entrapment in the Retinal Microcirculation of Diabetic Rats

Effect of Adenosine on Outward Active Transport of Fluorescein across Rabbit Blood Retinal Barrier

Effect of P2Y2 Receptor Agonist (INS542) on the Outward Permeability of the Retinal Pigment Epithelium

To View More...

You must be signed into an individual account to use this feature.